Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease

Despite the intense development of vaccines and antiviral therapeutics, no specific treatment of coronavirus disease 2019 (COVID-19), caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently available. Recently, X-ray crystallographic structures of a validated pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Frecer, Vladimir, Miertus, Stanislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057467/
https://www.ncbi.nlm.nih.gov/pubmed/35520818
http://dx.doi.org/10.1039/d0ra08304f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057467/
https://www.ncbi.nlm.nih.gov/pubmed/35520818
http://dx.doi.org/10.1039/d0ra08304f

Ejemplares similares